Surgery, anesthesia, and procedure planning

Peptide therapy before surgery or procedures: questions to ask your care team

A clinician-safe checklist for surgery, anesthesia, dental work, endoscopy, imaging, wound care, and cosmetic procedures when you use GLP-1s, sermorelin, PT-141, NAD+, glutathione, GHK-Cu, or methylene blue.

Procedure-safe peptide review

1

List every product: semaglutide, tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro, sermorelin, PT-141, NAD+, glutathione, GHK-Cu, methylene blue, supplements, and topicals.

2

Share timing and context: last dose or use, route, pharmacy label, GI symptoms, blood-sugar medicines, blood pressure, allergies, sleep apnea, infection, wound issues, and recent side effects.

3

Ask the prescriber and procedure team who decides whether anything should pause, continue, restart, or wait until after anesthesia, sedation, dental work, imaging, or wound healing.

4

Confirm practical logistics: medication labels, storage while away from home, refills, missed-dose questions, post-procedure nausea, hydration, nutrition, and urgent symptom escalation.

5

Avoid no-prescription sellers, research-use peptides, dose charts, or forum restart advice that bypass the clinician, anesthesiologist, dentist, surgeon, pharmacist, or primary-care team.

Direct answer

Tell the surgical, anesthesia, dental, or procedure team about every peptide or peptide-adjacent product before the appointment. Share the active ingredient, route, dose timing, pharmacy label, side effects, diabetes medicines, supplements, and whether the product is branded, compounded, or topical. Do not stop, restart, double, or combine medications without clinician instructions.

Definitions

A procedure review is broader than asking about one GLP-1 dose

Procedure planning can include surgery, anesthesia, deep or moderate sedation, endoscopy, dental procedures, injections, laser or cosmetic treatments, wound care, contrast imaging, and recovery instructions. Peptide therapy is also a broad category, so the review should identify the exact active ingredient, route, indication, pharmacy source, side effects, and whether other clinicians already manage the same condition.

  • Bring a current medication and supplement list, pharmacy labels, route, strength, recent dose timing, allergies, prior anesthesia problems, and the reason each product was prescribed or used.
  • Mention compounded prescriptions clearly. Compounded medications can be clinically useful when appropriate, but compounded finished products are not FDA-approved in the same way as approved brand-name drugs.
  • If the procedure team gives instructions, ask who should also update the peptide prescriber, pharmacy, primary-care clinician, endocrinologist, cardiologist, dentist, or surgeon.

GLP-1 and anesthesia context

GLP-1 medicines need individualized perioperative guidance

Semaglutide and tirzepatide products can delay stomach emptying and can cause nausea, vomiting, reflux, constipation, dehydration, or low intake. Current perioperative guidance emphasizes individualized risk review rather than a one-size-fits-all patient rule. Patients should tell the anesthesia and procedure team about GI symptoms, dose changes, diabetes medicines, prior aspiration risk, and whether they are taking a branded or compounded product.

  • Do not self-hold, restart, split, double, or “make up” GLP-1 medication around a procedure without clinician instructions.
  • If diabetes medicines are involved, ask who is responsible for glucose planning before and after the procedure.
  • Severe abdominal pain, persistent vomiting, dehydration, chest pain, trouble breathing, fainting, or blood in vomit or stool should be handled urgently, not through routine refill messaging.

Non-GLP and topical products

Non-GLP peptides, methylene blue, supplements, and topicals still matter

Sermorelin, PT-141/bremelanotide, NAD+, glutathione, GHK-Cu topical foam, low-dose oral methylene blue, and supplement stacks raise different questions. The procedure team may care about blood pressure, serotonergic medicines, G6PD status, allergies, bleeding or infection risk, wound healing, topical irritation, sedation medicines, and whether symptoms could be confused with medication side effects after the procedure.

  • Methylene blue requires medication review for serotonergic drugs, some opioids, psychiatric medicines, and G6PD deficiency; disclose it before anesthesia, sedation, or new prescriptions.
  • PT-141/bremelanotide discussions should include blood-pressure and cardiovascular context, especially if procedure stress, pain medicines, or sexual-health medicines are also involved.
  • Topical GHK-Cu or NAD+ products should not be applied to irritated, open, infected, freshly treated, or procedure-prepped skin unless the clinician or proceduralist says it is appropriate.

Patient safety checklist

Questions to ask before surgery or a procedure while on peptide therapy

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

✓

Which active ingredients, brands, compounded prescriptions, supplements, and topicals should I list for the surgeon, anesthesiologist, dentist, proceduralist, pharmacist, and primary-care clinician?

✓

Who decides whether each product should continue, pause, restart, or wait until after the procedure, and how will that instruction be documented?

✓

Do GLP-1 symptoms such as nausea, vomiting, reflux, constipation, dehydration, delayed stomach emptying, dose escalation, or diabetes medicines change anesthesia or fasting guidance?

✓

Do methylene blue, PT-141, sermorelin, NAD+, glutathione, GHK-Cu, sedatives, opioids, antibiotics, blood thinners, blood-pressure drugs, diabetes medicines, or supplements create interaction or side-effect questions?

✓

Should any recent labs, glucose readings, blood-pressure readings, kidney or liver tests, infection symptoms, wound problems, pregnancy questions, or specialist notes be reviewed before the procedure?

✓

What should I do if I miss a dose, have a delayed procedure, cannot eat normally, have vomiting or dehydration, develop an infection, or need a new medication after the procedure?

✓

Which symptoms need urgent care instead of a portal message, and who should handle after-hours questions: the procedure team, peptide prescriber, primary care, pharmacy, or emergency services?

✓

Does the clinic avoid generic dose charts, guaranteed clearance, no-prescription replacement peptides, research-use products, and advice that conflicts with anesthesia or surgical instructions?

FAQs

Short answers for patients

Should I tell my anesthesiologist or dentist about peptide therapy?

Yes. Share the active ingredient, route, dose timing, pharmacy label, side effects, allergies, diabetes medicines, supplements, and whether the product is branded, compounded, topical, or off-label for your goal. Procedure teams need a complete medication list to plan safely.

Do I need to stop semaglutide or tirzepatide before surgery?

Do not make your own stop or restart plan. GLP-1 guidance depends on symptoms, procedure type, anesthesia plan, diabetes status, dose changes, and the clinicians involved. Ask the prescribing clinician and procedure team for individualized written instructions.

Why do GLP-1 medicines matter for anesthesia?

Semaglutide and tirzepatide can delay gastric emptying and may cause nausea, vomiting, reflux, constipation, dehydration, or low intake. Those issues can affect anesthesia planning, fasting instructions, glucose planning, and whether symptoms should delay a procedure.

Do non-GLP peptides matter before a procedure?

Often yes. Sermorelin, PT-141, NAD+, glutathione, GHK-Cu, methylene blue, supplements, and topical products can raise questions about blood pressure, interactions, allergies, infection, wound or skin irritation, sedation medicines, and side-effect interpretation.

Can I use an online dosing chart if my procedure is delayed?

No. Delayed procedures, missed doses, restarts, fasting changes, vomiting, dehydration, infection, and new medicines should be handled by the prescribing clinician, pharmacy, and procedure team. Generic online dosing charts can be unsafe.

What symptoms are urgent around surgery or a procedure?

Seek urgent or emergency care for chest pain, trouble breathing, fainting, severe abdominal pain, persistent vomiting, severe dehydration, confusion, severe allergic symptoms, wound infection signs, blood in vomit or stool, or any symptom the procedure team labeled urgent.

Sources and related reading

Peptide12 pages use conservative educational language and authoritative sources where possible.

American Society of Anesthesiologists: New multi-society GLP-1 clinical practice guidanceAmerican Society of Anesthesiologists: 2023 consensus-based guidance on GLP-1 receptor agonists before proceduresMedlinePlus: Tests and visits before surgeryMedlinePlus: Anesthesia - what to ask your doctorDailyMed: Wegovy (semaglutide) prescribing informationDailyMed: Zepbound (tirzepatide) prescribing informationFDA: Compounding and the FDA, Questions and AnswersPeptide12: GLP-1 surgery and anesthesia questionsPeptide12: medication interaction reviewPeptide12: dose adjustment questionsPeptide12: missed dose planPeptide12: travel with peptide medicationsPeptide12: primary care coordinationPeptide12: read peptide medication labelsPeptide12: How online peptide therapy works